Product image of Metocard (Metoprolol Tartrate) supplied by GNH India

Metocard

Active Ingredient:
Metoprolol Tartrate
Origin:
EU

Metocard (Metoprolol Tartrate)

Metoprolol tartrate, the active ingredient in Metocard, is a selective β1‑adrenergic receptor blocker presented as an oral tablet for systemic use. It is indicated for the management of hypertension, angina pectoris, chronic heart failure, and post‑myocardial infarction in adult patients.

GNH India supplies Metocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under GMP conditions.

Manufacturer / TM Owner

Zaklady Farmaceutyczne Polpharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metocard (metoprolol tartrate) is a beta‑blocker used to manage cardiovascular conditions that involve elevated blood pressure or cardiac workload.
  • Hypertension: lowers systolic and diastolic blood pressure.
  • Angina pectoris: reduces myocardial oxygen demand and relieves chest pain.
  • Heart failure: improves left‑ventricular function and reduces hospitalisation risk.
  • Post‑myocardial infarction: decreases the likelihood of recurrent infarction and mortality.

How It Works

  • Metoprolol tartrate selectively antagonises β1‑adrenergic receptors in cardiac tissue, leading to a reduction in heart rate, myocardial contractility, and cardiac output. The drug also diminishes renin release from the kidneys, contributing to lower systemic vascular resistance and blood pressure.

Side Effects

Metocard may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Fatigue or tiredness
  • Dizziness or light‑headedness
  • Bradycardia (slow heart rate)
  • Cold extremities
  • Gastrointestinal upset (nausea, abdominal discomfort)
  • Sleep disturbances or vivid dreams

Serious or Rare Side Effects

  • Severe bradycardia or heart block
  • Marked hypotension
  • Bronchospasm, especially in patients with asthma or COPD
  • Acute decompensated heart failure
  • Depression or mood changes
  • Allergic reactions such as rash, angio‑edema, or anaphylaxis

Precautions & Warnings

  • When prescribing Metocard, clinicians should consider several safety measures.
  • Dose adjustment in renal impairment: reduce dose as needed.
  • Monitor heart rate and blood pressure: check regularly during therapy.
  • Avoid abrupt discontinuation: taper to prevent rebound hypertension.
  • Caution in asthma or COPD: may provoke bronchospasm.
  • Pregnancy and lactation: use only if benefits outweigh risks.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Avoid Interactions

Metocard can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid)

  • Concomitant use with non‑selective beta‑blockers: additive bradycardia.
  • Combination with calcium‑channel blockers (verapamil, diltiazem): risk of severe AV block.
  • Co‑administration with potent CYP2D6 inhibitors (e.g., quinidine, paroxetine): may increase plasma levels.
  • Concurrent clonidine withdrawal: precipitates hypertensive crisis.

Moderate Interactions (Monitor Closely)

  • Co‑administration with diuretics: may enhance hypotensive effect.
  • Use with insulin or oral hypoglycemics: may mask hypoglycaemia symptoms.
  • Concurrent NSAIDs: may reduce antihypertensive efficacy.

Frequently Asked Questions

Metocard contains metoprolol tartrate, a beta‑blocker that is prescribed for hypertension, angina pectoris, chronic heart failure, and for secondary prevention after a myocardial infarction. These indications target conditions where reducing heart rate and cardiac workload improves outcomes.

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, which slows the heart rate, decreases contractile force, and lowers cardiac output. It also reduces renin secretion from the kidneys, helping to lower systemic blood pressure.

The dose of Metocard is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage may be started low and titrated upward, but exact amounts should follow the prescriber’s instructions.

The safety of Metocard in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Metocard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metocard (metoprolol tartrate) is a cardio‑selective β1‑blocker, offering a favorable profile for patients with respiratory disease compared with non‑selective agents. Compared with extended‑release metoprolol succinate, the tartrate form is typically dosed multiple times daily and may be preferred for certain acute indications.

Metocard tablets should be stored at ambient temperature, below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Metocard is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance on timing relative to meals to ensure consistent absorption.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in susceptible individuals, and acute decompensated heart failure. Patients should seek immediate medical attention if they experience fainting, severe dizziness, shortness of breath, or chest pain.

Metocard is contraindicated in patients with known hypersensitivity to metoprolol or other beta‑blockers, those with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, cardiogenic shock, and uncontrolled asthma or severe chronic obstructive pulmonary disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoprolol Tartrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT